HK1057489A1 - Medicament for treating chronic hepatitis b - Google Patents

Medicament for treating chronic hepatitis b

Info

Publication number
HK1057489A1
HK1057489A1 HK04100492A HK04100492A HK1057489A1 HK 1057489 A1 HK1057489 A1 HK 1057489A1 HK 04100492 A HK04100492 A HK 04100492A HK 04100492 A HK04100492 A HK 04100492A HK 1057489 A1 HK1057489 A1 HK 1057489A1
Authority
HK
Hong Kong
Prior art keywords
chronic hepatitis
lactoferrin
remedies
treating chronic
medicament
Prior art date
Application number
HK04100492A
Other languages
English (en)
Inventor
Akiharu Watanabe
Kiyohiro Higuchi
Hirotoshi Hayasawa
Susumu Teraguchi
Koji Yamauchi
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of HK1057489A1 publication Critical patent/HK1057489A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK04100492A 2000-11-30 2004-01-21 Medicament for treating chronic hepatitis b HK1057489A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000365299 2000-11-30
PCT/JP2001/010490 WO2002043753A1 (fr) 2000-11-30 2001-11-30 Substances therapeutiques destinees a l'hepatite b chronique

Publications (1)

Publication Number Publication Date
HK1057489A1 true HK1057489A1 (en) 2004-04-08

Family

ID=18836097

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100492A HK1057489A1 (en) 2000-11-30 2004-01-21 Medicament for treating chronic hepatitis b

Country Status (5)

Country Link
JP (1) JP4087249B2 (fr)
KR (1) KR20030045025A (fr)
CN (1) CN1287855C (fr)
HK (1) HK1057489A1 (fr)
WO (1) WO2002043753A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100421656C (zh) * 2002-11-07 2008-10-01 明尼苏达大学评议会 乌索脱氧胆酸在制备治疗与出血相关的神经系统损伤的药物中的用途
JP2005247780A (ja) * 2004-03-05 2005-09-15 Masakazu Maruyama ウイルス性肝炎治療剤
WO2005094848A1 (fr) * 2004-03-31 2005-10-13 Calpis Co., Ltd. Agent visant à empêcher ou supprimer l'hépatopathie et aliment fonctionnel pour empêcher ou supprimer l'hépatopathie
US20090082269A1 (en) 2005-06-29 2009-03-26 Nrl Pharma, Inc. Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same
WO2008047391A1 (fr) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Composition nutraceutique comprenant de la lactoferrine et des probiotiques protéasiques
MX2011002045A (es) * 2008-08-28 2011-04-21 Chr Hansen As Composicion bacteriana.
CN107184613A (zh) * 2017-05-23 2017-09-22 山东大学 一种促进乙型肝炎病毒清除的益生菌组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2532911B2 (ja) * 1988-03-01 1996-09-11 森永乳業株式会社 有用細菌の腸内定着を促進する組成物
CA2338884A1 (fr) * 1998-07-30 2000-02-10 Morinaga Milk Industry Co., Ltd. Agents ameliorant la fonction hepatique
JP2000325046A (ja) * 1999-05-19 2000-11-28 Meiji Milk Prod Co Ltd 肝炎を予防および治療する食品もしくは医薬品

Also Published As

Publication number Publication date
KR20030045025A (ko) 2003-06-09
CN1287855C (zh) 2006-12-06
WO2002043753A8 (fr) 2003-03-06
CN1446099A (zh) 2003-10-01
WO2002043753A1 (fr) 2002-06-06
JPWO2002043753A1 (ja) 2004-04-02
JP4087249B2 (ja) 2008-05-21

Similar Documents

Publication Publication Date Title
CA2404387A1 (fr) Compositions de theanine favorisant le sommeil
WO2003094836A3 (fr) Methodes et produits permettant d'ameliorer des reponses immunitaires a l'aide de compose d'imidazoquinoline
TR200002299T2 (tr) Epotilon kompozisyonları.
WO2001027109A3 (fr) Derives de tert.-butyl-(methyl-imidazo[1,2-a]pyridine-3-yl)amine
WO2006125819A3 (fr) Forme medicamenteuse orale, microparticulaire, anti-mesusage
HK1123213A1 (en) Reduction of dizziness, a side effect associated with pirfenidone therapy
PL1883387T3 (pl) Pojemnik na płynne leki do podawania
HK1057489A1 (en) Medicament for treating chronic hepatitis b
WO2001052855A3 (fr) Association de medicaments pour le traitement de depressions et de troubles s'y rapportant, comprenant de la mirtazapine
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
MXPA04003851A (es) Antipruriticos.
WO2000053149A3 (fr) Procede et composition se rapportant a l'administration d'un inhibiteur de la cyclo-oxygenase-2
EP1197227A4 (fr) Procede d'administration de medicaments possedant une affinite de liaison aux proteines plasmatiques et preparation utilisee pour la mise en oeuvre dudit procede
EP1352657A4 (fr) Agents therapeutiques de potentialisation d'effet a base d'interferon
EP1550443A4 (fr) Composition pour lutter contre des maladies liees au stress
TW200509984A (en) Injectable dosage form of flupirtine
GB0018322D0 (en) Pharmaceutical compositions
TW200514582A (en) Transdermal preparation and method for reducing side effect in pergolide therapy
HK1079981A1 (en) A pharmaceutical preparation comprising a abacavirand alovudine and use thereof
NZ501987A (en) Single, high dosage intravenous administration of estramustine phosphate
EP1219297A4 (fr) Agents contre l'obesite
MXPA03002114A (es) Uso de arginina en la preparacion de un medicamento para la prevencion y tratamiento de los efectos secundarios asociados con la administracion intravenosa de productos farmaceuticos.
WO2002028380A3 (fr) Formes posologiques orales pour l'administration de la combinaison comprenant tegafur, uracile, acide folinique et irinotecan et leur procede d'utilisation
MY136408A (en) Active substance combinations and therapies for treating abuse of alcohol
UA41089A (uk) Спосіб профілактики йодного дефіциту у дітей

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE CHINESE NAME OF INVENTOR

Effective date: 20040811

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181130